Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.
Rosuvastatin was the leading molecule drug in cardiac segment in the Indian pharmaceutical market with a market value of almost ten billion Indian rupees in financial year 2020. Sun Pharmaceuticals, Glenmark and Mankind companies had a strong presence in top ten molecules that year.
Market value of leading molecules in the cardiac segment across India in financial year 2020 (in billion Indian rupees)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Cardiovascular disease in India
Overview
5
- Premium Statistic Deaths caused by chronic diseases 2019
- Basic Statistic Prevalence of select risk factors in cardiovascular disease deaths worldwide in 2016
- Basic Statistic Market share of cardiac market India FY 2020, by drug type
- Basic Statistic Market share of cardiac sales India FY 2020, by leading company
- Basic Statistic Penetrated market share in cardiac segment India FY 2020, by leading company
Heart disease
5
- Premium Statistic Share of people with heart problems India 2020, by age group
- Premium Statistic Share of people with cholesterol and heart problems India 2020, by gender
- Premium Statistic Risk of heart problems India 2019 by body mass index
- Premium Statistic Impact of cholesterol on heart issues among Indians 2019
- Premium Statistic Number of cases of heart disease in senior citizens India 2011-2050
Hypertension
4
- Premium Statistic Number of cases of hypertension in senior citizens India 2011-2050
- Premium Statistic Chronic disease incidence to treatment India 2019, by disease type
- Basic Statistic Value of hypertension market India FY 2020, by drug class
- Basic Statistic Share of hypertension market India FY 2020, by drug class
Leading cardiac therapies
4
- Basic Statistic Share of hypertension market India FY 2020, by drug class
- Basic Statistic Value of hyperlipidemia market India FY 2020, by drug class
- Basic Statistic Value of hypertension market India FY 2020, by drug class
- Basic Statistic Value of anti-thrombotic market India FY 2020, by drug class
Leading cardiac brands and molecules
7
- Basic Statistic Market value of leading brand in the cardiac segment India FY 2020
- Basic Statistic Market value of leading molecules in the cardiac segment India FY 2020
- Basic Statistic Market value of leading fastest growing molecules in cardiac segment India FY 2020
- Basic Statistic Number of one billion rupee brands in the cardiac segment India FY 2016-2020
- Basic Statistic Number of 500 million rupee brands in the cardiac segment India FY 2016-2020
- Basic Statistic Share of top five molecules in cardiac therapy India FY 2016-2020
- Basic Statistic Share of top ten molecules in cardiac therapy India FY 2016-2020
Leading market players
7
- Basic Statistic Glenmark Pharma' share of cardiac in IPM FY 2011-20
- Basic Statistic JB Chemicals' share of cardiac in IPM FY 2011-20
- Basic Statistic Dr.Reddy's laboratories' share of cardiac in Indian pharmaceutical market FY 2011-20
- Basic Statistic Cipla's share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Lupin's share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Torrent Pharmaceutical share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Sun Pharmaceuticals' share of cardiac in Indian pharmaceutical market FY 2011-2020
Further related statistics
18
- Drug therapy nonadherence rate in Canada in 2019, by therapy class
- Average FDA approved orphan drug sales U.S. 5 years after launch 2014
- Value of pharmaceutical product imports into the UK from EU countries 2023
- Usage of dispensed thyroid medicines in the Netherlands 2014-2022
- Cardiovascular system pharmaceutical consumption in Belgium 2008-2021
- Leading orphan drugs based on R&D phase III cost 2015
- Size of the global drug delivery systems market in 2016 and a forecast for 2025
- Vermont's medical cannabis sales value U.S. 2018-2024
- Number of cumulative orphan designations accepted in the U.S. 2003-2018
- Cardiovascular system pharmaceutical consumption in Sweden 2009-2022
- Projection of global Rx revenue share of orphan drugs 2010-2024
- Number of FDA approved orphan designations in the U.S. 2000-2014
- Dispensed thyroid medicines in the Netherlands 2014-2022
- Antibiotics in development as of May 2016, by clinical phase
- Jazz Pharmaceuticals R&D expenditure 2016-2023
- Value of the online market for OTC products in Poland 2017-2023
- Aurobindo Pharma's EBITDA FY 2013-2023
- Forecast: operating revenue medical laboratory equipment manufacture China 2008-2020
Further Content: You might find this interesting as well
Statistics
- Drug therapy nonadherence rate in Canada in 2019, by therapy class
- Average FDA approved orphan drug sales U.S. 5 years after launch 2014
- Value of pharmaceutical product imports into the UK from EU countries 2023
- Usage of dispensed thyroid medicines in the Netherlands 2014-2022
- Cardiovascular system pharmaceutical consumption in Belgium 2008-2021
- Leading orphan drugs based on R&D phase III cost 2015
- Size of the global drug delivery systems market in 2016 and a forecast for 2025
- Vermont's medical cannabis sales value U.S. 2018-2024
- Number of cumulative orphan designations accepted in the U.S. 2003-2018
- Cardiovascular system pharmaceutical consumption in Sweden 2009-2022
- Projection of global Rx revenue share of orphan drugs 2010-2024
- Number of FDA approved orphan designations in the U.S. 2000-2014
- Dispensed thyroid medicines in the Netherlands 2014-2022
- Antibiotics in development as of May 2016, by clinical phase
- Jazz Pharmaceuticals R&D expenditure 2016-2023
- Value of the online market for OTC products in Poland 2017-2023
- Aurobindo Pharma's EBITDA FY 2013-2023
- Forecast: operating revenue medical laboratory equipment manufacture China 2008-2020
HDFC Securities. (September 29, 2020). Market value of leading molecules in the cardiac segment across India in financial year 2020 (in billion Indian rupees) [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/1202009/india-market-value-of-leading-molecules-in-cardiac-segment/
HDFC Securities. "Market value of leading molecules in the cardiac segment across India in financial year 2020 (in billion Indian rupees)." Chart. September 29, 2020. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/1202009/india-market-value-of-leading-molecules-in-cardiac-segment/
HDFC Securities. (2020). Market value of leading molecules in the cardiac segment across India in financial year 2020 (in billion Indian rupees). Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/1202009/india-market-value-of-leading-molecules-in-cardiac-segment/
HDFC Securities. "Market Value of Leading Molecules in The Cardiac Segment across India in Financial Year 2020 (in Billion Indian Rupees)." Statista, Statista Inc., 29 Sep 2020, https://www.statista.com/statistics/1202009/india-market-value-of-leading-molecules-in-cardiac-segment/
HDFC Securities, Market value of leading molecules in the cardiac segment across India in financial year 2020 (in billion Indian rupees) Statista, https://www.statista.com/statistics/1202009/india-market-value-of-leading-molecules-in-cardiac-segment/ (last visited May 13, 2024)
Market value of leading molecules in the cardiac segment across India in financial year 2020 (in billion Indian rupees) [Graph], HDFC Securities, September 29, 2020. [Online]. Available: https://www.statista.com/statistics/1202009/india-market-value-of-leading-molecules-in-cardiac-segment/